SweetBio, Inc. specializes in advanced wound care technologies that leverage the healing properties of collagen and Manuka honey. Their flagship products, APIS® and VERIS™, are designed to address both chronic and acute wounds effectively. APIS® is a bioengineered wound dressing that combines a collagen derivative, Manuka honey, and hydroxyapatite, which has been FDA-cleared for managing various types of wounds, including diabetic ulcers and surgical wounds. This product not only protects the wound and absorbs exudate but also creates a moist environment conducive to healing. Clinical studies have demonstrated that APIS® can significantly reduce the time to wound closure, achieving results in as little as 4 to 8 weeks, which is notably faster than traditional treatments.

VERIS™ is another innovative offering from SweetBio, specifically designed for acute wounds, such as those resulting from skin cancer surgery or orthopedic procedures. Both products are characterized by their ease of application and mess-free use, making them accessible and user-friendly for patients and healthcare providers alike. SweetBio's commitment to affordability is evident as their products are covered by Medicare, ensuring that patients can access these advanced wound care solutions without financial burden. Overall, SweetBio, Inc. is dedicated to improving the quality of life for individuals with non-healing wounds through clinically proven, effective, and convenient wound care technologies.

United States

Simplifying your journey to closure with our collagen + honey advanced wound care products. #woundcareforall 
Sweetbio is a commercial-ready, medical device company with novel, honey-incorporated wound care products (FDA cleared May 2019).

SweetBio, Inc.

Company Details